Wellington Management Group’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $991K | Buy |
174,514
+21,393
| +14% | +$122K | ﹤0.01% | 1713 |
|
|
2025
Q1 | $729K | Buy |
153,121
+59,832
| +64% | +$285K | ﹤0.01% | 1765 |
|
|
2024
Q4 | $520K | Buy |
+93,289
| New | +$520K | ﹤0.01% | 1805 |
|
|
2021
Q1 | – | Sell |
-38,709
| Closed | -$1.52M | – | 2082 |
|
|
2020
Q4 | $1.52M | Sell |
38,709
-109,520
| -74% | -$4.3M | ﹤0.01% | 1538 |
|
|
2020
Q3 | $3.78M | Sell |
148,229
-32,616
| -18% | -$832K | ﹤0.01% | 1313 |
|
|
2020
Q2 | $13.2M | Sell |
180,845
-36,895
| -17% | -$2.69M | ﹤0.01% | 1014 |
|
|
2020
Q1 | $11.4M | Sell |
217,740
-41,026
| -16% | -$2.15M | ﹤0.01% | 1008 |
|
|
2019
Q4 | $21.2M | Buy |
258,766
+92,197
| +55% | +$7.54M | ﹤0.01% | 968 |
|
|
2019
Q3 | $9.41M | Buy |
166,569
+19,230
| +13% | +$1.09M | ﹤0.01% | 1182 |
|
|
2019
Q2 | $17.6M | Sell |
147,339
-21,328
| -13% | -$2.55M | ﹤0.01% | 1041 |
|
|
2019
Q1 | $31M | Buy |
168,667
+5,833
| +4% | +$1.07M | 0.01% | 886 |
|
|
2018
Q4 | $29.1M | Buy |
162,834
+31,349
| +24% | +$5.6M | 0.01% | 884 |
|
|
2018
Q3 | $42.1M | Buy |
131,485
+30,969
| +31% | +$9.91M | 0.01% | 857 |
|
|
2018
Q2 | $40.2M | Buy |
100,516
+15,930
| +19% | +$6.37M | 0.01% | 866 |
|
|
2018
Q1 | $30.3M | Buy |
84,586
+24,689
| +41% | +$8.86M | 0.01% | 932 |
|
|
2017
Q4 | $23.7M | Buy |
59,897
+51,598
| +622% | +$20.4M | 0.01% | 1019 |
|
|
2017
Q3 | $3.54M | Buy |
8,299
+686
| +9% | +$292K | ﹤0.01% | 1572 |
|
|
2017
Q2 | $1.22M | Sell |
7,613
-571
| -7% | -$91.4K | ﹤0.01% | 1826 |
|
|
2017
Q1 | $1.02M | Buy |
8,184
+1,212
| +17% | +$152K | ﹤0.01% | 1911 |
|
|
2016
Q4 | $845K | Buy |
+6,972
| New | +$845K | ﹤0.01% | 1894 |
|